May 11, 2010 Kidney injury Molecule-1 Outperforms Traditional Biomarkers of Kidney Injury in Preclinical Biomarker Qualification Studies
May 11, 2010 Towards Consensus Practices to Qualify Safety Biomarkers for Use in Early Drug Development
May 11, 2010 A Panel of Urinary Biomarkers to Monitor Reversibility of Renal Injury and a Serum Marker with Improved Potential to Assess Renal Function
April 10, 2010 Critical Path Institute President/CEO Receives Award of Excellence Raymond L. Woosley, MD, PhD, President/CEO of Tucson-based Critical Path Institute (CPI), was recently presented with the prestigi
March 23, 2010 First Annual Patient-Reported Outcome Consortium Workshop March 23, 2010 Sheraton Silver Spring Hotel 8777 Georgia Avenue – Silver Spring, MD 20910 SPONSORED BY: Critical Path Instit
March 11, 2010 Global Partners Join Forces to Speed Development of New TB Drug Combinations FDA applauds effort to take years off development of much needed TB treatments